Conclusions In stable COPD with neutrophilic bronchitis, add-on azithromycin therapy showed a trend to reduced severe exacerbations sputum neutrophils, CXCL8 levels and bacterial load.
← all excerpts
The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
1
—
—